...
首页> 外文期刊>Journal of neurointerventional surgery >European Stroke Organisation (ESO)-European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke
【24h】

European Stroke Organisation (ESO)-European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke

机译:欧洲中风组织(ESO) - 微创神经系统治疗(ESMINT)急性缺血性卒中机械血栓切除术指南

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Mechanical thrombectomy (MT) has become the cornerstone of acute ischemic stroke management in patients with large vessel occlusion (LVO). The aim of this guideline document is to assist physicians in their clinical decisions with regard to MT. Methods These guidelines were developed based on the standard operating procedure of the European Stroke Organisation, and followed the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. An interdisciplinary working group identified 15 relevant questions, performed systematic reviews and meta-analyses of the literature, assessed the quality of the available evidence, and wrote evidence based recommendations. Expert opinion was provided if not enough evidence was available to provide recommendations based on the GRADE approach. Results We found high quality evidence to recommend MT plus best medical management (BMM, including intravenous thrombolysis whenever indicated) to improve functional outcome in patients with LVO related acute ischemic stroke within 6 hours after symptom onset. We found moderate quality of evidence to recommend MT plus BMM in the 6-24 hour time window in patients meeting the eligibility criteria of published randomized trials. These guidelines further detail aspects of prehospital management, patient selection based on clinical and imaging characteristics, and treatment modalities. Conclusions MT is the standard of care in patients with LVO related acute stroke. Appropriate patient selection and timely reperfusion are crucial. Further randomized trials are needed to inform clinical decision making with regard to the mothership and drip-and-ship approaches, anesthaesia modalities during MT, and to determine whether MT is beneficial in patients with low stroke severity or large infarct volume.
机译:背景技术机械血栓切除术(MT)已成为大血管闭塞(LVO)患者急性缺血性卒中管理的基石。本指南文件的目的是协助医生在其临床决策方面关于MT。方法采用欧洲行程组织的标准操作程序开发了这些准则,并遵循建议,评估,开发和评估(等级)方法进行评分。跨学科工作组确定了15个相关问题,进行了系统的评价和荟萃分析,评估了可用证据的质量,并写了基于证据的建议。如果没有足够的证据,则提供专家意见,以便根据年级方法提供建议。结果我们发现高质量的证据推荐MT加上最佳医疗管理(每当指出时,包括静脉内溶栓),以改善症状发作后6小时内患有LVO相关急性缺血性卒中患者功能的功能结果。我们发现适度的证据,建议在符合公布的随机试验资格标准的患者的6-24小时时间窗口中推荐MT加BMM。这些指南进一步详细说明了预孢子管理,基于临床和成像特征的患者选择的方面,以及治疗方式。结论MT是患者相关急性卒中患者的护理标准。适当的患者选择和及时再灌注至关重要。需要进一步的随机试验,以便在MT期间,在母中性和滴水和船舶方法方面提供临床决策,并确定MT是否有益于中风严重程度或大梗塞体积的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号